Amble vs Levers Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Levers Health
Best for patients interested in GLP-1 microdosing for longevityStarting at $246/mo
Side-by-Side Comparison
| Feature | Amble | Levers Health |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.8/10 |
| Starting Price | ✓$179/mo | $246/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.4 ★ /5 |
| Features | 3 features | 3 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Levers Health
Pros
- ✓Named LLC entity
- ✓Microdose GLP-1 option for longevity
- ✓Both semaglutide and tirzepatide
Cons
- ✗No LegitScript or PCAB accreditation
- ✗No physical address disclosed
- ✗State availability not disclosed
- ✗FAQ/terms pages return 404
- ✗Above-average pricing ($247–$296/mo)
Our Verdict
Amble edges out Levers Health with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. Levers Health remains a solid alternative, especially if you're looking for patients interested in GLP-1 microdosing for longevity.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.